We are live on ! Find out more
SAM

Senzar Asset Management Portfolio holdings

AUM $34.7M
1-Year Est. Return 0.56%
This Fund
S&P 500
This Quarter Est. Return
+7.95%
1 Year Est. Return
+0.56%
3 Year Est. Return
-0.75%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$262M
AUM Growth
+$73M
Cap. Flow
+$51.4M
Cap. Flow %
19.63%
Top 10 Hldgs %
65.28%
Holding
27
New
9
Increased
11
Reduced
6
Closed
1

Top Buys

Rank Stock Value
1
QCOR
QUESTCOR PHARMA INC
QCOR
+$13.5M
2
INSM icon
Insmed
INSM
+$12.1M
3
VTRS icon
Viatris
VTRS
+$9.37M
4
MDT icon
Medtronic
MDT
+$8.94M
5
GSK icon
GSK
GSK
+$8.72M

Top Sells

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$8.61M
2
AGN
Allergan Inc
AGN
+$7.46M
3
MDVN
MEDIVATION, INC.
MDVN
+$5.68M
4
BIIB icon
Biogen
BIIB
+$5.57M
5
OFIX icon
Orthofix Medical
OFIX
+$3.5M

Sector Composition

Rank Sector Weight
1 Healthcare 81.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TVTX icon
26
Travere Therapeutics
TVTX
$5.33B
$1.86M 0.71%
+158,100
New +$2.14M
BIIB icon
27
Biogen
BIIB
$29.9B
– –
-18,200
Closed -$5.57M
1
2

Similar funds

BCP
Blum Capital Partners San Francisco, California $34.1M AUM 1.14% 1-Year Est. Return
PRHC
P.R. Herzig & Co Roslyn Heights, New York $45.9M AUM 15.88% 1-Year Est. Return
NAM
Needelman Asset Management Ladera Ranch, California $46M AUM 8.27% 1-Year Est. Return
GG
Gores Group Beverly Hills, California $22.3M AUM 4.58% 1-Year Est. Return
SM
SLS Management New York $17.2M AUM 14.82% 1-Year Est. Return
BC
Breogan Capital New York $56.4M AUM
SCPM
Social Capital PEP Management Palo Alto, California $56.5M AUM
FAM
Fortaleza Asset Management Chicago, Illinois $12.3M AUM 48.33% 1-Year Est. Return

Senzar Asset Management's Q2 2014 Portfolio in Review

As of Q2 2014, Senzar Asset Management held 27 positions worth $262M, up 39% from $189M the previous quarter. Its ten largest holdings account for 65% of the portfolio.

Senzar Asset Management deployed $51.4M of net new capital in Q2 2014, opening 9 new positions and adding to 11 existing holdings. Its largest new stake was QUESTCOR PHARMA INC: 158,100 shares worth $14.6M.

By sector, the portfolio is most concentrated in Healthcare at 81% of assets, down from 83% a quarter earlier.

On the sell side, the largest reduction was AbbVie, an estimated $8.61M trimmed.

  • Senzar Asset Management's largest Q2 2014 buy was QUESTCOR PHARMA INC: 158,100 shares worth $14.6M.
  • Senzar Asset Management added most to Enanta Pharmaceuticals in Q2 2014, an estimated $4.35M increase.
  • Senzar Asset Management's biggest Q2 2014 reduction was AbbVie, cutting an estimated $8.61M.
  • Senzar Asset Management fully exited Biogen in Q2 2014, selling an estimated $5.57M.
  • Senzar Asset Management's ten largest holdings make up 65% of its $262M portfolio in Q2 2014.
  • Senzar Asset Management opened 9 new positions and closed 1 in Q2 2014.
  • Senzar Asset Management's portfolio value rose 39% quarter-over-quarter to $262M.

Based on Senzar Asset Management's 13F filing for Q2 2014, filed 14 Aug 2014.